Dr. Mandip Dhamoon: “Health Risks After Stroke May Linger for at Least 5 Years: Study”

Two Mount Sinai Research Papers Present Evidence of Distinct Molecular Differences Between Brain Tissue from Living People and Tissue Collected After Death

NIH Awards Mount Sinai Researchers $25 Million to Study Alzheimer’s Disease and Risk Among Chinese Americans

BDSRA Foundation Announces Mount Sinai Health System as New Site in Clinical Centers of Excellence Program

New Protein Interaction Map Sheds Light on How Brain Cell Communication Breaks Down in Alzheimer’s Disease

Mount Sinai Receives $8 Million from DataPhilanthropy to Accelerate Drug Discovery for CADASIL and Related Brain Disorders

Mount Sinai Receives $3 Million Gift to Help Children With Spinal Cord Injuries and Cerebral Palsy Regain Mobility

New Framework for Characterizing Traumatic Brain Injury To Reveal More Detail About Patient’s Condition and Potential for Recovery

Mount Sinai Researchers Uncover a Promising New Way to Modulate Brain Cell Activity to Potentially Treat Major Depressive Disorder in Adults

Academy Award-Nominated Movie Helps Researchers Identify Brain Region Biased Towards Drug Cues and Treatment Effects in Individuals With Heroin Use Disorder

Discovery of Dopamine Receptors in a Previously Overlooked Part of the Brain Sheds Light on the Complex Circuitry for Anxiety and Depression

Mechanism by Which the Brain Weighs Positive vs. Negative Social Experience Is Revealed